CN1298702C - Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole - Google Patents
Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole Download PDFInfo
- Publication number
- CN1298702C CN1298702C CNB2005100384680A CN200510038468A CN1298702C CN 1298702 C CN1298702 C CN 1298702C CN B2005100384680 A CNB2005100384680 A CN B2005100384680A CN 200510038468 A CN200510038468 A CN 200510038468A CN 1298702 C CN1298702 C CN 1298702C
- Authority
- CN
- China
- Prior art keywords
- allyl group
- allyl
- reaction
- amine methyl
- methyl pyrrolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
The present invention discloses a method for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole, particularly a method for preparing a medicine intermediate product (s)-1-allyl-2-amidomethyl tetrahydropyrrole, which belongs to the technical field of the organic synthesis of a medicine intermediate product. The structural formula of the medicine intermediate product is disclosed in the specification. The preparing method comprises: the allylation reaction of L-prolyl amine used as a raw material, and the structural reduction reaction of acid amide in allylation products. The product prepared by the present invention can be used as a PET imaging agent <18>F-fallypride of a dopamine D2 receptor, and intermediate products of other medicine for treating mental disorders, and has wide application. The present invention has the advantages of simple preparing technology, easy operation, little pollution, safe preparation and high yield.
Description
Technical field
The present invention relates to a kind of d2 dopamine receptor PET developer
18The preparation method of the intermediate of F-fallypride and other mental disorder medicines (s)-1-allyl group-2-amine methyl Pyrrolidine.Relate to the pharmaceutical intermediate technical field of organic synthesis.
Background technology
Along with China's economy and social development, industrialization, urbanization, aging population process are accelerated, and spirit and behavioral problem have become important public health problem of China and comparatively outstanding social concern.Known have multiple neural psychotic disorder all relevant with expression with the function of DA acceptor, these diseases mainly contain motion sickness (as Parkinson's disease, Parkinsonism, huntington's chorea, carrying out property coker paralysis, multiple system atrophy and Wilson ' s disease), schizophrenia and emotionally disturbed, and some specific neuroendocrine disorders.Cerebral receptor imaging is the unique inspection method of nuclear medicine, utilizes single photon tomography (SPECT) and positron emission tomography (PET) (PET), understands the quantity and the changing function of these morbid states DA acceptor, will help the diagnosis and differential diagnosis of these diseases.
18F-fallypride is a kind of well behaved novel d2 dopamine receptor PET developer.Its synthetic route is as follows:
By said synthesis route as seen, (s)-1-allyl group-2-amine methyl Pyrrolidine is the novel d2 dopamine receptor developer of preparation
18The important intermediate of F-fallypride.Now do not have any producer both at home and abroad this intermediate finished product can be provided.Relevant synthetic this intermediate literature summary is as follows:
It is raw material that US4335045 adopts tetrahydrofurfuryl amine, through with hydrogen chloride gas and thionyl chloride effect open loop after obtain 2,5-dichloropentane base amine hydrochlorate; Again itself and excess acetyl chloride are got N-ethanoyl-2,5-dichloropentane base amine; Make 1-allyl group-2-amine methyl Pyrrolidine through allylation and deacetylated reaction more at last.This technology products therefrom is a racemic modification compound and raw material is perishable, severe reaction conditions, and separating difficulty is big.
It is raw material that EP0253785 adopts the L-proline(Pro), makes (s)-1-allyl group-pyrrolidine 2 carboxylic acid ester with the allyl bromide 98 reaction; Again itself and sodium cyanide are reacted in ammoniacal liquor and make (s)-1-allyl group pyrrole amides; After two (2-methoxy ethoxy) sodium aluminum hydride reduce (s)-1-allyl group-2-amine methyl Pyrrolidine.The still complicated and raw materials used severe toxicity of this reaction scheme easily causes environmental pollution.
Jogeshwar Mukherjee (Acta Chemica Scandinavica, 1989,43:660～664) has simplified reactions steps, and it is a raw material with the L-prolineamide, makes (s)-1-allyl group pyrrole amides with the allyl iodide reaction; Under-78 ℃, promptly get (s)-1-allyl group-2-amine methyl Pyrrolidine-78 ℃ of reduction again through diisobutyl aluminium hydride.This operational path is simple, reaction yield is moderate, but raw materials used as allyl iodide, diisobutyl aluminium hydride cost an arm and a leg and unstable, the very low temperature reaction conditions is very harsh, is unfavorable for suitability for industrialized production.
Summary of the invention
The preparation method who the purpose of this invention is to provide a kind of (s)-1-allyl group-2-amine methyl Pyrrolidine.
Technical scheme of the present invention, reaction formula is:
Comprise the following steps: successively
A) L-prolineamide (1) and allyl bromide 98 are carried out allylation reaction under the condition that soda ash exists, get (s)-1-allyl group pyrrole amides (2);
B) (s)-1-allyl group pyrrole amides (2) and tetra lithium aluminium hydride are carried out the reduction of amide reaction, get (s)-1-allyl group-2-amine methyl Pyrrolidine (3);
Concrete technology is:
A) allylation reaction:
1) the L-prolineamide is dissolved in the tetrahydrofuran (THF), stirs adding allyl bromide 98 and anhydrous sodium carbonate down, charging capacity mol ratio: L-prolineamide: allyl bromide 98: anhydrous sodium carbonate is 1: 1: 0.5;
2) after refluxing 24 hours under 80 ℃, be cooled to room temperature;
3) transfer to pH＞10 with sodium hydroxide solution, use dichloromethane extraction, merge organic phase;
4) drying, solvent recuperation gets white crystal;
B) reduction of amide reaction:
1) tetra lithium aluminium hydride is dissolved in the tetrahydrofuran (THF), ice bath drips the tetrahydrofuran solution that contains (s)-1-allyl group pyrrole amides down, charging capacity mol ratio: tetra lithium aluminium hydride: (s)-and 1-allyl group pyrrole amides is 1: 1;
2) ice bath reacted 0.5 hour down, refluxed 24 hours down in 80 ℃ then, was cooled to room temperature;
3) add an amount of sodium hydroxide solution, filter, filtrate is used extracted with diethyl ether, merges organic phase;
4) drying, solvent recuperation get (s)-1-allyl group-2-amine methyl Pyrrolidine crude product;
5) crude product is got finished product (s)-1-allyl group-2-amine methyl Pyrrolidine through underpressure distillation or column chromatography.
Beneficial effect of the present invention: product (the s)-1-allyl group-2-amine methyl Pyrrolidine of the present invention's preparation is as d2 dopamine receptor PET developer
18The intermediate of F-fallypride and other mental disorder medicines, of many uses; Preparation technology of the present invention is simple, easy to operate, it is little to pollute, production safety, yield height.
Embodiment
The present invention will be further described below in conjunction with example.
Embodiment 1
(s)-preparation method of 1-allyl group-2-amine methyl Pyrrolidine comprises the following steps: successively
1, allylation reaction
1) 10g (87.7mmol) (1) is dissolved in the 250ml tetrahydrofuran (THF), adds anhydrous sodium carbonate 5g (43.9mmol) and 7.5ml allyl bromide 98 (87.7mmol).
2) 80 ℃ of following backflows were cooled to room temperature after 24 hours.
3) transfer to pH＞10 with sodium hydroxide solution.With dichloromethane extraction (100ml * 4), merge organic phase.
4) the anhydrous sodium sulfate drying solvent recuperation gets white crystal (2) (12.5g, productive rate 92.3%), mp78～80 ℃.
2, reduction of amide reaction
1) 1.2g tetra lithium aluminium hydride (28mmol) is dissolved in the 100ml anhydrous tetrahydro furan, and ice bath drips 25ml down and contains 4.0g (2) tetrahydrofuran solution (26mmol).
2) under ice bath, reacted 0.5 hour.The back is cooled to room temperature after refluxing 24 hours under 80 ℃.
3) add the 50ml10% sodium hydroxide solution, filter.Filtrate merges organic phase with anhydrous diethyl ether extraction (50ml * 4).Anhydrous sodium sulfate drying, concentrated organic phase gets the safran oily liquids.
Purification step
4a) safran oily liquids underpressure distillation (20mmHg, 80 ℃) gets colourless oil liquid (3) (2.32g, productive rate 63.37%).MS(m/z)：141(M
++H)，110。IR(KBr)γ(cm
-1)：3292，2959，2870，1675，1442，994，914。
4b) (stationary phase: silica gel, moving phase: methylene chloride/ammoniacal liquor=60/40/1), solvent recuperation gets colourless oil liquid (3) (2.00g, productive rate 54.9%) to safran oily liquids column chromatography.
Claims (1)
1, the preparation method of a kind of (s)-1-allyl group-2-amine methyl Pyrrolidine is characterized in that reaction formula is:
Comprise the following steps: successively
A) L-prolineamide (1) and allyl bromide 98 are carried out allylation reaction under the condition that soda ash exists, get (s)-1-allyl group pyrrole amides (2);
B) (s)-1-allyl group pyrrole amides (2) and tetra lithium aluminium hydride are carried out the reduction of amide reaction, get (s)-1-allyl group-2-amine methyl Pyrrolidine (3);
Concrete technology is:
A) allylation reaction:
1) the L-prolineamide is dissolved in the tetrahydrofuran (THF), stirs adding allyl bromide 98 and anhydrous sodium carbonate down, charging capacity mol ratio: L-prolineamide: allyl bromide 98: anhydrous sodium carbonate is 1: 1: 0.5;
2) after refluxing 24 hours under 80 ℃, be cooled to room temperature;
3) transfer to pH＞10 with sodium hydroxide solution, use dichloromethane extraction, merge organic phase;
4) drying, solvent recuperation gets white crystal;
B) reduction of amide reaction:
1) tetra lithium aluminium hydride is dissolved in the tetrahydrofuran (THF), ice bath drips the tetrahydrofuran solution that contains (s)-1-allyl group pyrrole amides down, charging capacity mol ratio: tetra lithium aluminium hydride: (s)-and 1-allyl group pyrrole amides is 1: 1;
2) ice bath reacted 0.5 hour down, refluxed 24 hours down in 80 ℃ then, was cooled to room temperature;
3) add an amount of sodium hydroxide solution, filter, filtrate is used extracted with diethyl ether, merges organic phase;
4) drying, solvent recuperation get (s)-1-allyl group-2-amine methyl Pyrrolidine crude product;
5) crude product is got finished product (s)-1-allyl group-2-amine methyl Pyrrolidine through underpressure distillation or column chromatography.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100384680A CN1298702C (en) | 2005-03-15 | 2005-03-15 | Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100384680A CN1298702C (en) | 2005-03-15 | 2005-03-15 | Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1683335A CN1683335A (en) | 2005-10-19 |
| CN1298702C true CN1298702C (en) | 2007-02-07 |
Family
ID=35262862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100384680A Expired - Fee Related CN1298702C (en) | 2005-03-15 | 2005-03-15 | Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1298702C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101962353B (en) * | 2009-07-24 | 2013-11-06 | 凯惠科技发展(上海)有限公司 | Preparation method of (R) or (S)-2-aminomethyl tetrahydropyrrole |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253785A1 (en) * | 1986-05-22 | 1988-01-20 | Astra Lakemedel Aktiebolag | Efficient stereoconservative syntheses of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines and intermediates therein |
-
2005
- 2005-03-15 CN CNB2005100384680A patent/CN1298702C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253785A1 (en) * | 1986-05-22 | 1988-01-20 | Astra Lakemedel Aktiebolag | Efficient stereoconservative syntheses of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines and intermediates therein |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1683335A (en) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1298702C (en) | Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole | |
| CN102140103A (en) | Method for preparing 7-amino-3-hydro cephalosporanic acid by taking penicillin G/K as raw material | |
| CN109369611B (en) | Synthetic method of 4-chlorothiophene-2-carbonyl derivative | |
| Song et al. | A facile approach to spirocyclic butenolides through cascade cyclization/oxidative cleavage reactions of (Z)-enynols catalyzed by gold under dioxygen atmosphere | |
| US6713044B2 (en) | Synthesis of [2H1, 13C], [2H2, 13C] and [2H3, 13C]methyl aryl sulfides | |
| CN100457743C (en) | Prepn process of chiral 4-substituent-2-oxazolidone | |
| CN104496981A (en) | 2,2-dithienyl-2-hydroxycaproic acid-R-quinine-3-ester compound and preparation method thereof | |
| CN1733701A (en) | Method for asymmetrical hydrogen transfer of alpha-imino keton for synthesizing chirality salbutamol | |
| CN110317170B (en) | Green synthesis method of 3-phenanthridinyl propyl formate compound | |
| CN1305876C (en) | One-step method for preparing high-purity cefpoxime proxetil | |
| CN1939924A (en) | Industrial production of Fallopeinan sodium | |
| CN101486696B (en) | Preparation of 2,5-dimethyl furan-3,4-dicarboxylic acid | |
| CN1094119C (en) | New synthesizing method of 2-(2-substituting ethyl) cyclohexanone | |
| CN1884284A (en) | Process for the preparation of sodium faropenem | |
| Hendra et al. | Asymmetric Michael reaction between a chiral α, β-dimethyl-β-enamino ester and α-substituted acrylates | |
| CN1927853A (en) | Preparation method of racemic homocitric acid lactone | |
| CN104892491B (en) | Method for synthesizing paroxetine chiral intermediate | |
| CN1089522A (en) | Chiral copper catalyst ligand and synthetic method thereof | |
| CN1308305C (en) | Method for synthesizing imide base substituted endo compound | |
| CN1189458C (en) | Method for producing high purity antimer of (2s,3s)-1-tert-butoxy carbonyl-3-hydroxy-2-phenyl piperidine | |
| CN110305083B (en) | Process for preparing 5-chloromethyl furfural from fructose | |
| CN101054360A (en) | Method for preparing N-substituted acryloyl-2,5-pyrrole-dione compound | |
| CN1243738C (en) | Method for preparing 1-proparagyl hydantoin | |
| CN1760173A (en) | Method for synthesizing o-aminophenylpropyl alcohol | |
| KR20100023627A (en) | Bicyclo furan derivatives and the method for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |